(Q51061792)

28 March 2018

title

Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. (English)

1 reference

28 March 2018

transitional cell carcinoma

main subject

1 reference

1 reference

7

Ruth Knuechel

1 reference

28 March 2018

4

Christian Stief

1 reference

28 March 2018

Arndt Hartmann

6

object named as

Arndt Hartmann

1 reference

28 March 2018

author name string

Edwin Hungerhuber

1

1 reference

28 March 2018

Herbert Stepp

2

1 reference

28 March 2018

Martin Kriegmair

3

1 reference

28 March 2018

Alfons Hofstetter

5

1 reference

28 March 2018

Alexander Karl

8

1 reference

28 March 2018

Stefan Tritschler

9

1 reference

28 March 2018

Dirk Zaak

10

1 reference

28 March 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

28 March 2018

published in

Urology

1 reference

28 March 2018

volume

69

1 reference

28 March 2018

issue

2

1 reference

28 March 2018

page(s)

260-264

1 reference

28 March 2018

Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Serial multiple-site biopsies in patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

The accuracy of urinary cytology in daily practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

The current diagnosis of superficial bladder cancer must be reconsidered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Bladder carcinoma in situ in 2003: state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Natural history of urothelial dysplasia of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Flat intraepithelial lesions of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Recurrence and progression in low grade papillary urothelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

A second-look TUR in T1 transitional cell carcinoma: why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

Prevention and treatment of urothelial premalignant and malignant lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2006.10.015

1 reference

28 March 2018

1 reference

28 March 2018